Intermittent glucocorticoid treatment enhances skeletal muscle performance through sexually dimorphic mechanisms is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 0. It has been cited 38 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the National Institutes of Health
Grant: AR052646,HL061322,DK121875,HL141698,AR073655,DK007169
NINDS NIH HHS
Grant: R01 NS047726
NIAMS NIH HHS
Grant: F31 AR073655
NHLBI NIH HHS
Grant: R01 HL061322
NHLBI NIH HHS
Grant: R56 HL158531
NIAMS NIH HHS
Grant: U54 AR052646
NHLBI NIH HHS
Grant: K99 HL141698
NIDDK NIH HHS
Grant: K01 DK121875
NHLBI NIH HHS
Grant: R00 HL141698
NIAMS NIH HHS
Grant: P50 AR052646
NIDDK NIH HHS
Grant: T32 DK007169
National Institutes of Health
Grant: 5U54AR052646-02
Modulation of Muscle Growth for the Muscular Dystrophies
National Institutes of Health
Grant: 5F31AR073655-02
Dose-specific responsiveness of glucocorticoid receptor-driven transcription in skeletal muscle
National Institutes of Health
Grant: 1K01DK121875-01
Glucocorticoid and circadian clock coregulation of insulin sensitivity and metabolism
National Institutes of Health
Grant: 5R01HL061322-05
SARCOGLYCAN IN MYOPATHY AND MUSCLE MEMBRANE STABILITY
National Institutes of Health
Grant: 5K99HL141698-02
Myofilament proteins in cardiomyopathy and arrhythmias
FWCI
2.92
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals